Halia Therapeutics has completed the enrolment in its Phase IIa trial of HT-6184 (Ofirnoflast) in those with lower-risk ...

The discovery of CSMD1's role in epilepsy represents a crucial step forward in unravelling the genetic mysteries of epilepsy.

Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today ...

Sharp Rise in Turmeric-Linked Liver Injuries . According to a new study published in The American Journal of Medicine , ...

Tempus AI Inc. (NASDAQ:TEM) announced the introduction of xM for treatment response monitoring/TRM. This new liquid biopsy ...

Based on published data from four populations, the date of origin of the diabetes protective PPARG Ala12 variant was estimated using both allele frequency and linkage disequilibrium (LD) with the ...

The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.

A new genomic study has unlocked the genetic secrets behind the breeding of flowering Chinese cabbage—a popular leafy ...

Panelists discuss how to communicate genomic testing results to patients and make shared treatment decisions, particularly when multiple targeted therapy options are available for patients with ESR1 ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...